logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Richard G. Langley

Dalhousie University
H指数:77
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND

特应性皮炎中度至重度患者接受特立珠单抗治疗长达6年的长期安全性与有效性：开放标签扩展试验ECZTEND的最终结果

Dermatology and Therapy
IF4.2
2026-02-050
OAAI
Andrew Blauvelt; H. Chih-Ho Hong; Norito Katoh; Richard G. Langley; Vivian Laquer; Aleksandra Lesiak; Ketty Peris; Julien Seneschal; Juan-Francisco Silvestre; Richard B. Warren; Andreas Wollenberg; Matthew Zirwas; Niels Højsager Bennike; Farzaneh Safavimanesh; Ann-Marie Tindberg; Kristian Reich
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals

慢性累积性生命历程损伤是否被纳入银屑病管理？——一项针对银屑病患者和医疗保健专业人士的多国调查

Dermatology and Therapy
IF4.2
2025-11-220
OAAI
Raymond Matthews; April W. Armstrong; Matthias Augustin; Christopher Baker; José Manuel Carrascosa; Brian Kirby; Richard Langley; Sandy McBride; Adam Reich; Ricardo Romiti; Francesca Sampogna; Richard B. Warren
Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis

中重度特应性皮炎成人患者中曲尼司特长达4年的疗效

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
IF8
2025-11-011
OAAI
Gooderham, Melinda; Ameen, Mahreen; Hong, H. Chih-ho; Katoh, Norito; Langley, Richard G.; Peris, Ketty; Reich, Kristian; Silvestre, Juan F.; Simpson, Eric; Werfel, Thomas; Gjerum, Le; Tindberg, Ann-marie; Oland, Christian Bjerregard; Blauvelt, Andrew
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials

特应性皮炎患者中特立洛金单抗的安全性（随访长达4.5年）：一项八项临床试验的整合分析

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2025-11-011
OAAI
Reich, Kristian; Langley, Richard G.; Silvestre Salvador, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew E.; Paller, Amy S.; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Blauvelt, Andrew; Bjerregard Oland, Christian; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric L.
SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement

SPECTREM IIIb期临床 trial 结果（16周）：guselkumab 治疗低体表面积、中度银屑病伴高影响部位受累的疗效与安全性

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2025-10-011
OAAI
Gold, Linda Stein; Gottlieb, Alice B.; Armstrong, April W.; Alkousakis, Theodore; Bissonnette, Robert; Langley, Richard G.; Krueger, James; Papp, Kim; Choi, Olivia; Rowland, Katelyn; Chan, Daphne; Jeyarajah, Jenny; Park-Wyllie, Laura; Gao, Long-Long; Gordon, Kenneth B.; Merola, Joseph F.; Lebwohl, Mark G.; Strober, Bruce
Time to Onset of Action for Biologics and Targeted Treatments in Psoriasis: Systematic Targeted Literature Review and Network Meta-Analysis

生物制剂和靶向治疗在银屑病中的作用起始时间：系统靶向文献综述和网络Meta分析

Dermatology and Therapy
IF4.2
2025-07-170
OA
Kim A. Papp; Ron Vender; Kerri Purdy; Fiona Lovegrove; Irina Oroz; Parbeer Grewal; Perla Lansang; Laura Park-Wyllie; Nastaran Abbarin; Ya-Wen Yang; Becky Hooper; Sandra Vigelis; Tim Disher; Richard G. Langley
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial

Bimekizumab在斑块状银屑病中至重度患者中的疗效持久性（至196周）和安全性（至4年）：BE BRIGHT开放标签扩展试验结果

Journal of the American Academy of Dermatology
IF11.8
2025-04-240
OA
Andrew Blauvelt; Richard G. Langley; Mark Lebwohl; Bruce Strober; Richard B. Warren; Luis Puig; Akimichi Morita; Kenneth B. Gordon; Pablo Fernandez-Peñas; Sarah Kavanagh; José M. López Pinto; Jérémy Lambert; Bengt Hoepken; Delphine Deherder; Nancy Cross; Diamant Thaçi
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)

奥瑞司米拉斯特，一种磷酸二酯酶4B/D抑制剂，在轻中度特应性皮炎中的疗效与安全性：一项多中心随机安慰剂对照的IIb期剂量探索研究（ADESOS）的疗效与安全性

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2025-01-072
PRE
Silverberg, Jonathan, I; Eichenfield, Lawrence F.; Blauvelt, Andrew; Irvine, Alan D.; Guttman-Yassky, Emma; Langley, Richard G.; Warren, Richard B.; French, Lars E.; Felding, Jakob; Weiss, Anne; Pedersen, Claus B.; Jensen, Morten L.; Carlsson, Anna; Sommer, Morten O. A.; Kjoller, Kim; Simpson, Eric L.
Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
IF8
2024-08-160
PRE
Torres, T.; Brembilla, N. C.; Langley, R. G.; Warren, R. B.; Thaci, D.; Kolios, A. G. A.; Prinz, J. C.; Londono-Garcia, A.; Nast, A.; Santin, M.; Goletti, D.; Abreu, M.; Spuls, P.; Boehncke, W. H.; Puig, L.
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials

tralokinumab治疗治疗4.5年特应性皮炎患者的安全性: 对8项临床试验的最新综合分析

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2024-08-080
PRE
Reich, Kristian; Langley, Richard G.; Silvestre, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew; Paller, Amy; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric
Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)
BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2024-08-080
PRE
Silverberg, Jonathan; Eichenfield, Lawrence; Blauvelt, Andrew; Irvine, Alan D.; Langley, Richard; Guttman, Emma; Warren, Richard; French, Lars; Pedersen, Claus Bang; Carlsson, Anna; Jensen, Morten Lind; Sommer, Morten O. A.; Kjoller, Kim; Simpson, Eric
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
IF11.8
2024-06-010
PRE
Chat, Vipawee S.; Ellebrecht, Christoph T.; Kingston, Paige; Gondo, George; Bell, Stacie; Cordoro, Kelly M.; Desai, Seemal R.; Duffin, Kristina C.; Feldman, Steven R.; Garg, Amit; Gelfand, Joel M.; Gladman, Dafna; Green, Lawrence J.; Gudjonsson, Johann; Han, George; Hawkes, Jason E.; Kircik, Leon; Koo, John; Langley, Richard; Lebwohl, Mark; Lewitt, G. Michael; Liao, Wilson; Martin, George; Orbai, Ana-Maria; Reddy, Soumya M.; Richardson, Veronica; Ritchlin, Christopher T.; Schwartzman, Sergio; Siegel, Evan L.; Van Voorhees, Abby S.; Wallace, Elizabeth B.; Weinberg, Jeffrey M.; Winthrop, Kevin L.; Yamauchi, Paul; Armstrong, April W.
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)

Orismilast治疗中度至重度银屑病: 一项为期16周，随机，双盲，安慰剂对照，剂量发现和2b期试验 (IASOS) 的疗效和安全性

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
IF11.8
2024-03-015
OAAI
Warren, Richard B.; French, Lars E.; Blauvelt, Andrew; Langley, Richard G.; Egeberg, Alexander; Mrowietz, Ulrich; Hunter, Hamish J. A.; Gooderham, Melinda; Soerensen, Per; Andres, Philippe; Sommer, Morten O. A.; Carlsson, Anna; Kjoller, Kim D.; Strober, Bruce E.
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials

tralokinumab治疗治疗4.5年特应性皮炎患者的安全性: 对8项临床试验的最新综合分析

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2024-02-070
PRE
Reich, Kristian; Langley, Richard G.; Silvestre, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew; Paller, Amy; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric
Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control

持续tralokinumab治疗成人中度至重度特应性皮炎超过4年提供长期的疾病控制

BRITISH JOURNAL OF DERMATOLOGY
IF9.6
2024-02-071
PRE
Blauvelt, Andrew; Langley, Richard G.; Peris, Ketty; Silvestre, Juan Francisco; Katoh, Norito; Tauber, Marie; Pinter, Andreas; Ameen, Mahreen; Gooderham, Melinda; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Reich, Kristian
Using Artificial Intelligence as a Melanoma Screening Tool in Self-Referred Patients

在自我推荐的患者中使用人工智能作为黑色素瘤筛查工具

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
IF3.9
2023-12-296
OAAI
Crawford, Madeleine E.; Kamali, Kiyana; Dorey, Rachel A.; Macintyre, Olivia C.; Cleminson, Kristyna; Macgillivary, Michael L.; Green, Peter J.; Langley, Richard G.; Purdy, Kerri S.; Decoste, Ryan C.; Gruchy, Jennette R.; Pasternak, Sylvia; Oakley, Amanda; Hull, Peter R.

研究方向

暂未获取到该数据
K
Kristian Reich
H 指数:104论文数:746被引数:4.2万
K
Kim Papp
H 指数:106论文数:818被引数:4.9万
M
Mark Lebwohl
H 指数:120论文数:1,415被引数:5.5万
R
Richard B. Warren
H 指数:69论文数:705被引数:1.7万
A
Andrew Blauvelt
H 指数:92论文数:809被引数:3.7万
K
Kenneth B. Gordon
H 指数:73论文数:309被引数:2.5万
B
Bruce Strober
H 指数:65论文数:482被引数:1.9万
A
Alan Menter
H 指数:96论文数:538被引数:4.0万
A
Alice B. Gottlieb
H 指数:111论文数:864被引数:4.9万
C
C. Paul
H 指数:90论文数:907被引数:2.8万